4Q30
Nitrowillardiine bound to the ligand binding domain of GluA2 at pH 3.5
Summary for 4Q30
| Entry DOI | 10.2210/pdb4q30/pdb |
| Related | 3RTW |
| Descriptor | Glutamate receptor 2 CHIMERIC PROTEIN, 3-(5-nitro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-L-alanine, ZINC ION, ... (4 entities in total) |
| Functional Keywords | glutamate receptor, glua2, glur2, ampa receptor, lbd, neurotransmitter receptor, nitrowillardiine, transport protein |
| Biological source | Rattus norvegicus (brown rat,rat,rats) More |
| Cellular location | Cell membrane; Multi-pass membrane protein: P19491 |
| Total number of polymer chains | 3 |
| Total formula weight | 87481.46 |
| Authors | Ahmed, A.H.,Oswald, R.E. (deposition date: 2014-04-10, release date: 2014-06-04, Last modification date: 2024-11-20) |
| Primary citation | Martinez, M.,Ahmed, A.H.,Loh, A.P.,Oswald, R.E. Thermodynamics and mechanism of the interaction of willardiine partial agonists with a glutamate receptor: implications for drug development. Biochemistry, 53:3790-3795, 2014 Cited by PubMed Abstract: Understanding the thermodynamics of binding of a lead compound to a receptor can provide valuable information for drug design. The binding of compounds, particularly partial agonists, to subtypes of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor is, in some cases, driven by increases in entropy. Using a series of partial agonists based on the structure of the natural product, willardiine, we show that the charged state of the ligand determines the enthalpic contribution to binding. Willardiines have uracil rings with pKa values ranging from 5.5 to 10. The binding of the charged form is largely driven by enthalpy, while that of the uncharged form is largely driven by entropy. This is due at least in part to changes in the hydrogen bonding network within the binding site involving one water molecule. This work illustrates the importance of charge to the thermodynamics of binding of agonists and antagonists to AMPA receptors and provides clues for further drug discovery. PubMed: 24850223DOI: 10.1021/bi500511m PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.03 Å) |
Structure validation
Download full validation report






